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Background
Precise quantification of myocardial amyloid burden may
improve the diagnosis and monitoring of cardiac amyloi-
dosis (CA). While late gadolinium enhancement (LGE)
imaging by MRI demonstrates a characteristic pattern of
infiltration, it does not quantify the extent of myocardial
extracellular matrix expansion which occurs in CA. We
tested the hypothesis that a direct measure of myocardial
extracellular volume fraction (MECVF) using T1-weighted
imaging pre- and post-contrast can identify CA.
Methods
We performed 3T cardiac MRI in 47 subjects including
9 control subjects (mean age 45±11 years, 66.7% female)
and 38 consecutive patients (mean age 68±15 years,
23.7% female) referred with (1) known CA, (2) unex-
plained left ventricular hypertrophy or (3) a systemic
disease susceptible of infiltrating the myocardium
(2 amyloidosis, 2 monoclonal gammopathy). MRI
included cine imaging and LGE 10 min after 0.15
mmol/Kg of gadolinium. In addition, a Look-Locker gra-
dient echo technique with adiabatic inversion was used,
once before and 3 times over a 30-min period after
gadolinium injection, to quantify T1. The myocardial
partition coefficient was estimated by least-squares lin-
ear regression of R1 (1/T1) in myocardium against R1
in blood. MECVF was obtained by adjusting the parti-
tion coefficient by the patient’s hematocrit. LV subendo-
cardial and subepicardial LGE was blindly graded as
present or absent using a 17-segment model.
Results
In this cohort, 13 (27.6%) patients were confirmed to have
CA by biopsy and 4 (8.5%) were diagnosed with probable
CA by clinical evaluation, 21 (44.7%) patients had a non
infiltrative cardiomyopathy (7 hypertensive cardiomyopa-
thies, 2 patients with ventricular arrhythmias, 1 with an
extracardiac glycogen storage disease, 1 hypertrophic car-
diomyopathy, 10 cardiomyopathies of undefined etiology).
Mean MECVF was substantially higher in patients with
CA than in the non infiltrative cardiomyopathy group and
in normal controls (p<0.0001 vs. non infiltrative cardio-
myopathy, p=0.0001 vs. controls and p=0.1742 vs. prob-
able CA, Figure 1). MECVF demonstrated a strong
correlation with the extent of LGE (r=0.77, p<0.0001) and
with LV mass index (r=0.69, p<0.0001) and an inverse
correlation with LVEF (r=-0.55, p=0.0002).
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Figure 1 Myocardial extracellular volume fraction according to final
diagnosis
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Direct quantification of extracellular matrix expansion by
MECVF may characterize the burden of CA infiltration.
Elevated MECVF is associated with higher extent of LGE
and increased LV mass index. This novel quantitative
method may aid in the differential diagnosis of infiltrative
heart disease and in the recognition of CA. It also holds
promises for monitoring the response to therapy.
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